XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer

Clinical trial NCT00417079 · COMPLETED

Trial details

NCT number: NCT00417079
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms Prostatic Neoplasms

Start date: 2007-01-01
Primary completion: 2009-09-01
Enrollment: 755

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.